Medicine News and Research

RSS

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure.

24 Jan 2011

Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Thursday, January 20, 2011, it submitted a Post Approval Supplement containing data supporting the removal of the Indium-111 ZEVALIN® pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.

24 Jan 2011

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.

24 Jan 2011

KineMed's fibrosis research program featured in Nature Medicine

KineMed Inc.'s fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

24 Jan 2011

Northwest Biotherapeutics resumes enrollment in DCVax Phase II clinical trial for GBM brain cancer

Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.

24 Jan 2011

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

Raptor Pharmaceutical Corp., today announced it has completed enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Jan 2011

PHA concerned over negative impact on patient care by Section 6001 of Healthcare Reform

Physician Hospitals of America (PHA) is deeply concerned about the negative impact on patient care caused by Section 6001 of Healthcare Reform which prohibits new construction or expansion of physician owned hospitals (POHs). Since its passage, section 6001 has prevented or impeded progress for 37 new hospitals, more than 40 nearly-finished hospital construction projects, and approximately 20 major expansion projects.

24 Jan 2011

Global Poverty Summit addresses MDGs, global trade policy

At the Global Poverty Summit January 16-19 in Johannesburg, South Africa, "academics, policy-makers, civil society activists and development workers ... agreed that the [U.N. Millennium Development Goals] MDGs have made a difference, but have fallen far short of the ambitious targets on poverty, education, health, gender equality and global partnership that 189 countries committed to achieving by 2015," IRIN reports.

24 Jan 2011

China Shenghuo's Lixuwang product recieves Chinese Well-Known Trademark Honor

China Shenghuo Pharmaceutical Holdings, a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine, nutritional supplement and cosmetic products, today announced that "Lixuwang", the trademark of its best selling product, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the State Administration for Industry and Commerce of China.

24 Jan 2011

Eliminating sugary drinks from diet can reduce tooth decay in American Indian children

A study conducted in four American Indian communities in the Pacific Northwest presents an effective strategy to convince mothers to switch young children from drinking sweetened soda to water and shows that eliminating these sugary drinks from the diets of the youngest members of the tribe significantly decreased tooth decay.

24 Jan 2011

Scientists ignore relevant drug clinical trials when conducting new research on same topic

The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.

24 Jan 2011

Boehringer Ingelheim's Prazaxa receives Japanese approval for stroke prevention in AF patients

The Ministry of Health, Labour and Welfare in Japan today approved dabigatran etexilate, Boehringer Ingelheim's novel, oral direct thrombin inhibitor under the brand name Prazaxa for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation marking the first approval of a novel oral anticoagulant in the Asia-Pacific region and specifically Japan in nearly 50 years.

24 Jan 2011

Two studies explore relationship between nutrition and asthma

Asthma is one of the world's most common chronic diseases, affecting as many as 300 million people. It is estimated that by 2025 there could be an additional 100 million people with the disease. This rapid increase in asthma is most likely due to changing environmental or lifestyle factors, and over the last 15 years, changing diet has emerged as a promising contributor. Two studies published in the in the February 2011 issue of the Journal of the American Dietetic Association explore the possible relationship between nutrition and asthma.

24 Jan 2011

Los Angeles Society of Pathologists honors LA BioMed researcher with Lifetime Achievement Award

The Los Angeles Society of Pathologists, Inc. presented its Lifetime Achievement Award to Samuel W. French, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, on Jan. 15.

24 Jan 2011

College of Osteopathic Medicine receives grant to develop training program for medical students

Nova Southeastern University's medical school, the College of Osteopathic Medicine, recently received a $2.3 million federal grant to develop an academic curriculum to train medical and other students in the health professions to better meet the needs of patients in a changing national health care system.

24 Jan 2011

Bluecross awards UTHSC $2,912,751 grant to promote patient safety

The University of Tennessee Health Science Center has been awarded a $2,912,751 grant from the BlueCross BlueShield of Tennessee Health Foundation to fund its "Promoting Patient Safety Through Teamwork-Focused Interdisciplinary Simulations Program."

24 Jan 2011

Researchers identify key player that lead to increased bleeding in diabetes patients with stroke injury

Strokes are a leading cause of mortality and adult disability. Those that involve intracerebral hemorrhage are especially deadly, and there are no effective treatments to control such bleeding. Moreover, diabetes and hyperglycemia are associated with increases in bleeding during hemorrhagic stroke and worse clinical outcomes.

24 Jan 2011

Stusy: HEPA filters may help reduce pollution-related cardiovascular health risks

Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adultsliving in a small community in British Columbia where wood burning stoves are the main sources of pollution.

24 Jan 2011

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.

23 Jan 2011

First U.S. implant of RespiCardia System for treatment of sleep apnea

Cardiac Concepts, announced today the first U.S. clinical implant of the RespiCardia System at The Ohio State University Medical Center, Columbus, Ohio.

21 Jan 2011

Medicine News and Research

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

KineMed's fibrosis research program featured in Nature Medicine

Northwest Biotherapeutics resumes enrollment in DCVax Phase II clinical trial for GBM brain cancer

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

PHA concerned over negative impact on patient care by Section 6001 of Healthcare Reform

Global Poverty Summit addresses MDGs, global trade policy

China Shenghuo's Lixuwang product recieves Chinese Well-Known Trademark Honor

Eliminating sugary drinks from diet can reduce tooth decay in American Indian children

Scientists ignore relevant drug clinical trials when conducting new research on same topic

Boehringer Ingelheim's Prazaxa receives Japanese approval for stroke prevention in AF patients

Two studies explore relationship between nutrition and asthma

Los Angeles Society of Pathologists honors LA BioMed researcher with Lifetime Achievement Award

College of Osteopathic Medicine receives grant to develop training program for medical students

Bluecross awards UTHSC $2,912,751 grant to promote patient safety

Researchers identify key player that lead to increased bleeding in diabetes patients with stroke injury

Stusy: HEPA filters may help reduce pollution-related cardiovascular health risks

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

First U.S. implant of RespiCardia System for treatment of sleep apnea

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News